Research News

A novel light-activated nanotherapy developed by researchers at the University of Colorado- Boulder may be an effective weapon against the drug-resistant bacteria, say researchers including one of Indian-origin.

Cranberry extracts can help fighting urinary tract infections (UTIs) or bladder infection in breast-fed babies less than one year of age, new research says

Greater intake of dietary nitrate and green leafy vegetables is associated with a 20-30 percent lower risk of primary open-angle glaucoma (POAG), according to a study.

The US Food and Drug Administration cleared the Olympus TJF-Q180V duodenoscope with modifications to the device’s design and labeling intended to help reduce the risk of bacterial infections. Olympus will voluntarily recall its original model currently being used in health care facilities and make the needed repair as quickly as possible.

Heron Therapeutics, Inc., announced that the U.S. Food and Drug Administration (FDA) has informed the Company that it has not yet completed its review of the New Drug Application (NDA) of SUSTOL® (granisetron) Injection,extended release and would not be taking action by the Prescription Drug User Fee Act (PDUFA) goal date of January 17, 2016 and anticipates taking action in late February 2016.

Nivalis Therapeutics, Inc., a clinical stage pharmaceutical company focused on developing innovative solutions for people with cystic fibrosis (“CF”),  announced the U.S. Food and Drug Administration ("FDA") has granted Orphan Drug Designation to the Company's lead investigational drug, N91115, a novel stabilizer of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.

Researchers are likely to have uncovered a novel mechanism behind the ability of the common diabetes drug - metformin -- to inhibit the progression of pancreatic cancer.

Bone marrow lesions (BMLs) are likely to help predict a swiftly progressing joint disease, says a study.

Researchers have found a way to make an existing drug used to treat breast, lung and pancreatic cancers effective in small dosage, thereby reducing its usage and associated side effects in course of the treatment.

The risk of developing colorectal cancer in obese people is about 50 percent greater compared to the risk in lean people, says new research.